Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pau Abrisqueta

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Journal of Clinical Medicine|April 13, 2024
New Insights into First-Line Therapy in Diffuse Large B-Cell Lymphoma: Are We Improving Outcomes?Pau Abrisqueta
Blood|March 13, 2020
Venetoclax-obinutuzumab: harnessing complexityPau Abrisqueta, Francesc Bosch
Blood and Lymphatic Cancer : Targets and Therapy|July 31, 2019
Plasmablastic lymphoma: current perspectivesAndres Lopez, Pau Abrisqueta
Blood|November 7, 2015
Ibrutinib in CLL: 2 sides of the same coinFrancesc Bosch, Pau Abrisqueta
Expert Review of Hematology|February 17, 2011
Personalizing treatment for chronic lymphocytic leukemiaPau Abrisqueta, Marta Crespo, Francesc Bosch
British Journal of Haematology|May 11, 2026
Response to 'Statistical considerations in the comparison of immunotherapy and chemotherapy for POD24 follicular lymphoma'Ángel Serna, Víctor Navarro, Pau Abrisqueta
Annals of Hematology|August 11, 2021
Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysisGuillermo Villacampa, Rodrigo Dienstmann, Francesc Bosch, et al.
Best Practice & Research. Clinical Haematology|August 25, 2009
Gene expression profiling in chronic lymphocytic leukaemiaCarles Codony, Marta Crespo, Pau Abrisqueta, et al.
Gastroenterologia Y Hepatologia|April 19, 2015
[Importance of hepatitis B virus screening in hematological patients]Mar Riveiro-Barciela, Gonzalo Artaza, Pau Abrisqueta, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 4, 2019
Acquired von Willebrand syndrome in a patient with small lymphocytic lymphoma and Sjögren's syndrome: which associated condition should be prioritized?José Pardos-Gea, Fernanda Martínez, Pau Abrisqueta, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|April 13, 2024
New Insights into First-Line Therapy in Diffuse Large B-Cell Lymphoma: Are We Improving Outcomes?Pau Abrisqueta
Blood|March 13, 2020
Venetoclax-obinutuzumab: harnessing complexityPau Abrisqueta, Francesc Bosch
Blood and Lymphatic Cancer : Targets and Therapy|July 31, 2019
Plasmablastic lymphoma: current perspectivesAndres Lopez, Pau Abrisqueta
Blood|November 7, 2015
Ibrutinib in CLL: 2 sides of the same coinFrancesc Bosch, Pau Abrisqueta
Expert Review of Hematology|February 17, 2011
Personalizing treatment for chronic lymphocytic leukemiaPau Abrisqueta, Marta Crespo, Francesc Bosch
British Journal of Haematology|May 11, 2026
Response to 'Statistical considerations in the comparison of immunotherapy and chemotherapy for POD24 follicular lymphoma'Ángel Serna, Víctor Navarro, Pau Abrisqueta
Annals of Hematology|August 11, 2021
Combination of novel molecular targeted agent plus R-CHOP-based regimen versus R-CHOP alone in previously untreated diffuse large B-cell lymphoma (DLBCL) patients: a systematic review and meta-analysisGuillermo Villacampa, Rodrigo Dienstmann, Francesc Bosch, et al.
Best Practice & Research. Clinical Haematology|August 25, 2009
Gene expression profiling in chronic lymphocytic leukaemiaCarles Codony, Marta Crespo, Pau Abrisqueta, et al.
Gastroenterologia Y Hepatologia|April 19, 2015
[Importance of hepatitis B virus screening in hematological patients]Mar Riveiro-Barciela, Gonzalo Artaza, Pau Abrisqueta, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 4, 2019
Acquired von Willebrand syndrome in a patient with small lymphocytic lymphoma and Sjögren's syndrome: which associated condition should be prioritized?José Pardos-Gea, Fernanda Martínez, Pau Abrisqueta, et al.
Pageof 12